Bharat Biotech seeks EUA for Covaxin
No date has been fixed as on when the SEC will meet for assessing and evaluating the applications, as per sources
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Bharat Biotech
Modi visits key vaccine facilities as COVID-19 case load surges
The Prime Minister Narendra Modi toured three of the nation’s leading vaccine development and manufacturing sites on Saturday as…
Bharat Biotech commences Phase III trials for COVAXIN
Phase III trials will involve 26,000 volunteers across India who will receive two intramuscular injections, approximately 28 days…
Bharat Biotech to manufacture Covaxin from Odisha
Dr Ella informs that the best of the technology will be put in the Odisha unit at a total investment of around Rs 300 crores
Covaxin may get launched in February 2021: ICMR scientist
The company had earlier hoped to launch it only in the second quarter of next year.
Bharat Biotech plans Covaxin launch in second quarter of 2021, post requisite approvals
Immediate focus is to conduct Phase 3 trial successfully
Bharat Biotech in talks with many countries for clinical trials, manufacture of COVAXIN
The countries are located in South America, Asia and Central Asia, and Eastern Europe
COVAXIN from Bharat Biotech gets DCGI nod for Phase III clinical trials
The approval was given based on the recommendation of an expert panel at the CDSCO
Serum India, Bharat Biotech to test intranasal COVID-19 vaccines post regulatory nod: Dr Harsh…
He clarified that Phase III clinical trial is generally with thousands of participants, sometimes even close to 30,000 to 40,000…
Bharat Biotech told to provide phase II data of Covaxin before phase III trial
The SEC also observed that the vaccine was well-tolerated in all dose groups and no serious adverse events have been reported so…